📰
Politics
Robeauté Bets on Rice-Sized Microrobots for Brain Disease
📅14 August 2026 at 10:12
📰Bloomberg
👁️1 views
Share:
✅
Full Article Content Loaded
Complete article with 505 characters of detailed content
Full Article•Reading time: ~2 min•79 words
ℹ️
Chrome Audio Reader: This audio reader has been optimized for Chrome's speech synthesis. If you experience issues, try using Edge or Firefox as they have more reliable speech synthesis.
Chrome Known Issues: Chrome sometimes has voice loading delays. The system will automatically retry with simplified settings if needed. For best results, try Edge or Firefox browsers.
🔇
Audio Reader
Not supported in this browser
The CEO of French neurotechnology startup Robeauté says its microrobot could unlock precise delivery of drugs and other therapies directly into the brain,
The microrobots, which are each the size of grain of rice, are able to reach areas that are difficult to access with existing treatments.
Joana Cartocci says the company is targeting first-in-human studies in 2027 and a market launch in the early 2030s.
She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe. (Source: Bloomberg)
Article Details
📰Source: Bloomberg
⚡Content fetched on-demand for optimal performance
✨Enhanced with BBC-inspired formatting
Reading Statistics
505
Characters
79
Words
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.